
    
      This study is a prospective, single arm, non-randomized, multi-center clinical study that
      will be conducted at up to thirteen centers in Europe. It is designed to assess efficacy and
      safety of the VirtueÂ® Male Sling. One hundred and twenty-one subjects, satisfying criteria
      for selection, will be implanted with no more than 15 implanted per site. The study's primary
      end point will be evaluated at 12 months with continued data collection through 36 months.
    
  